Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page
- Check7 days agoChange DetectedUpdated the site footer “Revision” label on the record history page from v3.5.2 to v3.5.3. This reflects a platform/version change rather than any modification to the underlying trial record history.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedA new revision entry (v3.5.0) was added to the history while an older entry (v3.4.3) was removed, reflecting a platform-level update to how revisions are tracked.SummaryDifference0.1%

- Check57 days agoChange DetectedStudy record history shows Revision: v3.4.3, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page history shows a minor revision from v3.4.1 to v3.4.2; no content or functionality changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedThe history shows Revision v3.4.1 replacing v3.4.0, a metadata update that does not affect study details or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.